SCOPUS 정보 검색 플랫폼

Volumn 26, Issue 10, 2008, Pages 1764-1765

Modification of tamoxifen response: What have we learned?

(9) Lash, Timothy L a Ahern, Thomas P a Cronin Fenton, Deirdre b Garne, Jens Peter c Hamilton Dutoit, Stephen b Kvistgaard, Marianne Ewertz c Rosenberg, Carol L d Silliman, Rebecca A d Sørensen, Henrik Toft b

a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH (United States)

b AARHUS UNIVERSITY HOSPITAL (Denmark)

c AALBORG UNIVERSITY HOSPITAL (Denmark)

d BOSTON UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; TAMOXIFEN; ESTROGEN RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADJUVANT THERAPY; BREAST CANCER; CANCER RECURRENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; LETTER; PRIORITY JOURNAL; RISK FACTOR; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; ALLELE; BREAST TUMOR; DRUG RESISTANCE; FEMALE; GENETICS; METABOLISM; NOTE; PHARMACOGENETICS;

ALLELES; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYTOCHROME P-450 CYP2D6; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; PHARMACOGENETICS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 43249097854 PISSN: 0732183X EISSN: None Source Type: Journal
DOI: 10.1200/JCO.2007.15.5432 Document Type: Letter

Times cited : (10)

References (7)

1
- 36849092797
- Germline pharmacogenetics of tamoxifen response: Have we learned enough?
- Desta Z, Flockhart DA: Germline pharmacogenetics of tamoxifen response: Have we learned enough? J Clin Oncol 25:5147-5148, 2007
- (2007) J Clin Oncol , vol.25 , pp. 5147-5148
- Desta, Z.¹ Flockhart, D.A.²

2
- 29144491089
- Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients
- Wegman P, Vainikka L, Stal O, et al: Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients. Breast Cancer Res 7:R282-R290, 2005
- (2005) Breast Cancer Res , vol.7
- Wegman, P.¹ Vainikka, L.² Stal, O.³

3
- 21344467511
- Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients
- Nowell SA, Ahn J, Rae JM, et al: Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Res Treat 91:249-258, 2005
- (2005) Breast Cancer Res Treat , vol.91 , pp. 249-258
- Nowell, S.A.¹ Ahn, J.² Rae, J.M.³

4
- 34248208754
- Genetic variants of CYP2A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer
- Wegman P, Elingarami S, Carstensen J, et al: Genetic variants of CYP2A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer. Breast Cancer Res 9:R7, 2007
- (2007) Breast Cancer Res , vol.9
- Wegman, P.¹ Elingarami, S.² Carstensen, J.³

5
- 33847034287
- The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen
- Goetz MP, Knox SK, Suman VJ, et al: The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat 101:113-121, 2007
- (2007) Breast Cancer Res Treat , vol.101 , pp. 113-121
- Goetz, M.P.¹ Knox, S.K.² Suman, V.J.³

6
- 36349024762
- Breast cancer treatment outcome with adjuvant tamoxifen in relation to patient CYP2D6 and CYP2C19 genotypes
- Schroth W, Antoniadou L, Fritz P, et al: Breast cancer treatment outcome with adjuvant tamoxifen in relation to patient CYP2D6 and CYP2C19 genotypes. J Clin Oncol 25:5187-5193, 2007
- (2007) J Clin Oncol , vol.25 , pp. 5187-5193
- Schroth, W.¹ Antoniadou, L.² Fritz, P.³

7
- 0002520743
- Unbiased plotting positions: A review
- Cunnane C: Unbiased plotting positions: A review. J Hydrology 37:205-222, 1978
- (1978) J Hydrology , vol.37 , pp. 205-222
- Cunnane, C.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.